The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Opioid-Induced Glial Activation: Mechanisms of Activation and Implications for Opioid Analgesia, Dependence, and Reward
Open accessAbstract
This review will introduce the concept of toll-like receptor (TLR)-mediated glial activation as central to all of the following: neuropathic pain, compromised acute opioid analgesia, and unwanted opioid side effects (tolerance, dependence, and reward). Attenuation of glial activation has previously been demonstrated both to alleviate exaggerated pain states induced by experimental pain models and to reduce the development of opioid tolerance. Here we demonstrate that selective acute antagonism of TLR4 results in reversal of neuropathic pain as well as potentiation of opioid analgesia. Attenuating central nervous system glial activation was also found to reduce the development of opioid dependence, and opioid reward at a behavioral (conditioned place preference) and neurochemical (nucleus accumbens microdialysis of morphine-induced elevations in dopamine) level of analysis. Moreover, a novel antagonism of TLR4 by (+)- and (-)-isomer opioid antagonists has now been characterized, and both antiallodynic and morphine analgesia potentiating activity shown. Opioid agonists were found to also possess TLR4 agonistic activity, predictive of glial activation. Targeting glial activation is a novel and as yet clinically unexploited method for treatment of neuropathic pain. Moreover, these data indicate that attenuation of glial activation, by general or selective TLR antagonistic mechanisms, may also be a clinical method for separating the beneficial (analgesia) and unwanted (tolerance, dependence, and reward) actions of opioids, thereby improving the safety and efficacy of their use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An emerging body of evidence suggests that activated glia and glia-derived neuroinflammatory mediators play an important role in drug reward, dependence, tolerance and analgesic properties (Hutchinson et al., 2007).”
From Stress- and Glucocorticoid-Induced Priming of Neuroinflammatory Responses: Potential Mechanisms of Stress-Induced Vulnerability to Drugs of Abuse (2011) · cites this paper as Hutchinson et al., 2007
In the citing paper
“There is an emerging evidence that glia and glia-derived neuroinflammatory mediators play key roles in the development of drug abuse.”
From Stress- and Glucocorticoid-Induced Priming of Neuroinflammatory Responses: Potential Mechanisms of Stress-Induced Vulnerability to Drugs of Abuse (2011) · cites this paper as Hutchinson et al., 2007
In the citing paper
“Importantly, we have also shown that morphine and other clinically relevant opioids (oxycodone and methadone) function as TLR4 agonists using TLR4 transfected human embryonic kidney (HEK-293) cells (Hutchinson et al., 2007).”
From Stress- and Glucocorticoid-Induced Priming of Neuroinflammatory Responses: Potential Mechanisms of Stress-Induced Vulnerability to Drugs of Abuse (2011) · cites this paper as Hutchinson et al., 2007
In the citing paper
“Moreover, an overwhelming amount of evidence demonstrates that within the CNS, opioid administration leads to the activation of microglia via a toll-like receptor (TLR)-4-dependent mechanism, and produces paradoxical aggravation of proinflammatory immune responses (Hutchinson et al, 2007;Watkins et al, 2009).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Hutchinson et al, 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sindrup, S. H., & Jensen, T. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00154-2 · Cited by 1,142
Glial activation: a driving force for pathological pain
Watkins, L. R., Milligan, E. D., & Maier, S. F. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01854-3 · Cited by 1,091
Self-citationA systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramèr, M. R., Nye, B., Carroll, D., Wiffen, P. J., & Moore, A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 926
Major increases in opioid analgesic abuse in the United States: Concerns and strategies
Compton, W. M., & Volkow, N. D. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.009 · Cited by 824
Anticonvulsant drugs for management of pain: a systematic review
McQuay, H., Carroll, D., Jadad, A. R., Wiffen, P. J., & Moore, A. (1995) · BMJ · doi:10.1136/bmj.311.7012.1047 · Cited by 712
Spinal Glia and Proinflammatory Cytokines Mediate Mirror-Image Neuropathic Pain in Rats
Milligan, E. D., Twining, C. M., Chacur, M., Biedenkapp, J. C., O'Connor, K., Poole, S., Tracey, K. J., Martin, D. P., Maier, S. F., & Watkins, L. R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-03-01026.2003 · Cited by 701
Self-citationThe CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy
Tanga, F. Y., Nutile-McMenemy, N., & DeLeo, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501634102 · Cited by 634
Wybran, J., Appelboom, T., Famaey, J.-P., & Govaerts, A. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.3.1068 · Cited by 580
Why is Wallerian degeneration in the CNS so slow?
Vargas, M. E., & Barres, B. A. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094354 · Cited by 510
Vasudeva, R., Rutkowski, M. D., & DeLeo, J. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09980.2002 · Cited by 468
Research works printed but not linked: 2
- Tanga, F.Y., Nutile-McMenemy, N., and Deleo, J.A. (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. U. S. A. 102(16), 5856-5861.
- Watkins, L.R., Hutchinson, M.R., Zhang, Y., Coats, B.D., Sprunger, D.B., Hughes, T.S., Maier, S.F., Johnson, K.W., and Rice, K.C. (2007) Identification and characterization of a novel opioid site of action: implications for opioid- induced glial activation. In Press: Society for Neuroscience San Diego, CA.
Cited by
Sorted by citations
Pathological and protective roles of glia in chronic pain
Milligan, E. D., & Watkins, L. R. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2533 · Cited by 1,443
Self-citationPathological pain and the neuroimmune interface
Grace, P. M., Hutchinson, M. R., Maier, S. F., & Watkins, L. R. (2014) · Nature reviews. Immunology · doi:10.1038/nri3621 · Cited by 982
Self-citationIncidence, reversal, and prevention of opioid-induced respiratory depression
Dahan, A., Aarts, L., & Smith, T. W. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181c38c25 · Cited by 634
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
Hutchinson, M. R., Zhang, Y., Shridhar, M., Evans, J. H., Buchanan, M. M., Zhao, T. X., Slivka, P. F., Coats, B. D., Rezvani, N., Wieseler, J. L., et al. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.08.004 · Cited by 575
Self-citationMorphine activates neuroinflammation in a manner parallel to endotoxin
Wang, X., Loram, L. C., Ramos, K. M., de Jesus, A. J., Thomas, J., Cheng, K., Reddy, A., Somogyi, A. A., Hutchinson, M. R., Watkins, L. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200130109 · Cited by 521
Self-citationWatkins, L. R., Hutchinson, M. R., Rice, K. C., & Maier, S. F. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.002 · Cited by 438
Self-citationConsidering sex as a biological variable will require a global shift in science culture
Shansky, R. M., & Murphy, A. Z. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00806-8 · Cited by 442
Hutchinson, M. R., Zhang, Y., Brown, K., Coats, B. D., Shridhar, M., Sholar, P. W., Patel, S. J., Crysdale, N. Y., Harrison, J. A., Maier, S. F., et al. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06321.x · Cited by 399
Self-citationHutchinson, M. R., Shavit, Y., Grace, P. M., Rice, K. C., Maier, S. F., & Watkins, L. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.004135 · Cited by 397
Self-citationGrace, P. M., Strand, K. A., Galer, E. L., Urban, D. J., Wang, X., Baratta, M. V., Fabisiak, T., Anderson, N. D., Cheng, K., Greene, L. I., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602070113 · Cited by 379
Self-citationCytokine and Chemokine Regulation of Sensory Neuron Function
Miller, R. J., Jung, H., Bhangoo, S. K., & White, F. A. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-79090-7_12 · Cited by 367
Toll‐like receptor 4 in CNS pathologies
Buchanan, M. M., Hutchinson, M. R., Watkins, L. R., & Yin, H. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06736.x · Cited by 334
Self-citationProinflammatory cytokines oppose opioid-induced acute and chronic analgesia
Hutchinson, M. R., Coats, B. D., Lewis, S. S., Zhang, Y., Sprunger, D. B., Rezvani, N., Baker, E. M., Jekich, B. M., Wieseler, J. L., Somogyi, A. A., et al. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.05.004 · Cited by 307
Self-citationHutchinson, M. R., Lewis, S. S., Coats, B. D., Skyba, D. A., Crysdale, N. Y., Berkelhammer, D. L., Brzeski, A., Northcutt, A. L., Vietz, C. M., Judd, C. M., et al. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.09.012 · Cited by 306
Self-citationDonvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301
Toll-like receptors in chronic pain
Nicotra, L. L., Loram, L. C., Watkins, L. R., & Hutchinson, M. R. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.038 · Cited by 258
Self-citationNitrogen critical loads and management alternatives for N-impacted ecosystems in California
Fenn, M. E., Allen, E. B., WEISS, S. B., Jovan, S., Geiser, L. H., Tonnesen, G., Johnson, R. F., Rao, L. E., Gimeno, B., Yuan, F., et al. (2010) · Journal of Environmental Management · doi:10.1016/j.jenvman.2010.07.034 · Cited by 236
The therapeutic potential of interleukin-10 in neuroimmune diseases
Kwilasz, A. J., Grace, P. M., Šerbedžija, P., Maier, S. F., & Watkins, L. R. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.020 · Cited by 249
Self-citationKetamine and Peripheral Inflammation
Kock, M. D., Loix, S., & Lavand'homme, P. M. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12104 · Cited by 229
Eidson, L. N., & Murphy, A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1609-13.2013 · Cited by 167
Roles of β-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism
Pilozzi, A. R., Carro, C., & Huang, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010338 · Cited by 261
Schwarz, J. M., Hutchinson, M. R., & Bilbo, S. D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3297-11.2011 · Cited by 203
Self-citationColler, J. K., & Hutchinson, M. R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.008 · Cited by 186
Self-citationWatkins, L. R., Hutchinson, M. R., Milligan, E. D., & Maier, S. F. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.06.006 · Cited by 185
Self-citationHutchinson, M. R., Lewis, S. S., Coats, B. D., Rezvani, N., Zhang, Y., Wieseler, J. L., Somogyi, A. A., Yin, H., Maier, S. F., Rice, K. C., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.011 · Cited by 181
Self-citationHutchinson, M. R., Northcutt, A. L., Chao, L. W., Kearney, J. J., Zhang, Y., Berkelhammer, D. L., Loram, L. C., Rozeske, R. R., Bland, S. T., Maier, S. F., et al. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.07.008 · Cited by 180
Self-citationDoyle, H. H., Eidson, L. N., Sinkiewicz, D. M., & Murphy, A. Z. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2906-16.2017 · Cited by 166
Neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration
Alexander, J., & Popovich, P. G. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17508-8 · Cited by 163
Moloney, R. D., O’Mahony, S. M., Dinan, T. G., & Cryan, J. F. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00015 · Cited by 171
Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease
Rolan, P. E., Hutchinson, M. R., & Johnson, K. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903426189 · Cited by 160
Self-citationThe effect of gut microbiome on tolerance to morphine mediated antinociception in mice
Kang, M., Mischel, R. A., Bhave, S., Komla, E., Cho, A., Huang, C., Dewey, W. L., & Akbarali, H. I. (2017) · Scientific Reports · doi:10.1038/srep42658 · Cited by 154
The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release
Bland, S. T., Hutchinson, M. R., Maier, S. F., Watkins, L. R., & Johnson, K. W. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.01.014 · Cited by 152
Self-citationImmunoadolescence: Neuroimmune development and adolescent behavior
Brenhouse, H. C., & Schwarz, J. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.035 · Cited by 163
Glutamatergic transmission in drug reward: implications for drug addiction
D’Souza, M. S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00404 · Cited by 154
Eidson, L. N., Inoue, K., Young, L. J., Tansey, M. G., & Murphy, A. Z. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.131 · Cited by 140
Multimodal Pain Management in Veterinary Medicine: The Physiologic Basis of Pharmacologic Therapies
Lamont, L. A. (2008) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2008.06.005 · Cited by 136
Combination Drug Therapy for Chronic Pain: A Call for More Clinical Studies
Mao, J., Gold, M. S., & Bačkonja, M. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.07.006 · Cited by 134
Stopponi, S., Somaini, L., Cippitelli, A., Cannella, N., Braconi, S., Kallupi, M., Ruggeri, B., Heilig, M. A., Demopulos, G. A., Gaitanaris, G., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.010 · Cited by 136
Metz, V. E., Jones, J. D., Manubay, J. M., Sullivan, M. A., Mogali, S., Segoshi, A., Madera, G., Johnson, K. W., & Comer, S. D. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.70 · Cited by 133
Self-citationPrenatal opioid exposure: The next neonatal neuroinflammatory disease
Jantzie, L. L., Maxwell, J. R., Newville, J., Yellowhair, T. R., Kitase, Y., Madurai, N. K., Ramachandra, S., Bakhireva, L. N., Northington, F. J., Gerner, G. J., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.11.007 · Cited by 133
Glia in pathological pain: A role for fractalkine
Milligan, E. D., Sloane, E. M., & Watkins, L. R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.011 · Cited by 123
Self-citationTargeting Toll-like receptors with small molecule agents
Wang, X., Smith, C., & Yin, H. H. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60039d · Cited by 117
Frank, M. G., Watkins, L. R., & Maier, S. F. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.01.005 · Cited by 116
“An emerging body of evidence suggests that activated glia and glia-derived neuroinflammatory mediators play an important role in drug reward, dependence, tolerance and analgesic properties (Hutchinson et al., 2007).”
BackgroundSelf-citationNew perspectives in the diagnosis and management of enteric neuropathies
Knowles, C. H., Lindberg, G., Panza, E., & GIORGIO, R. D. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.18 · Cited by 113
Morphine‐enhanced apoptosis in selective brain regions of neonatal rats
Bajic, D., Commons, K. G., & Soriano, S. G. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.02.009 · Cited by 111
Inflammatory mediators of opioid tolerance: Implications for dependency and addiction
Eidson, L. N., & Murphy, A. Z. (2019) · Peptides · doi:10.1016/j.peptides.2019.01.003 · Cited by 108
Glial and neuroinflammatory targets for treating substance use disorders
Bachtell, R. K., Jones, J. D., Heinzerling, K. G., Beardsley, P. M., & Comer, S. D. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.08.003 · Cited by 116
Schrepf, A., O’Donnell, M. A., Luo, Y., Bradley, C. S., Kreder, K. J., & Lutgendorf, S. K. (2014) · Pain · doi:10.1016/j.pain.2014.05.029 · Cited by 105
Cathcart, S., Galatis, N., Immink, M., Proeve, M., & Petkov, J. (2014) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465813000234 · Cited by 102
Hutchinson, M. R., Loram, L. C., Zhang, Y., Shridhar, M., Rezvani, N., Berkelhammer, D. L., Phipps, S., Foster, P. S., Landgraf, K., Falke, J. J., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.067 · Cited by 102
Self-citationWhy is neuroimmunopharmacology crucial for the future of addiction research?
Hutchinson, M. R., & Watkins, L. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.039 · Cited by 100
Self-citationMechanisms of pain transmission and pharmacologic management
Argoff, C. E. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.614934 · Cited by 100
Opioid‐Induced Central Immune Signaling: Implications for Opioid Analgesia
Grace, P. M., Maier, S. F., & Watkins, L. R. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12552 · Cited by 104
Self-citationBeardsley, P. M., Shelton, K. L., Hendrick, E., & Johnson, K. W. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.010 · Cited by 97
Self-citationPharmacological characterization of LPS and opioid interactions at the toll‐like receptor 4
Stevens, C., Aravind, S., Das, S., & Davis, R. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12028 · Cited by 96
Targeting novel mechanisms of pain in sickle cell disease
Tran, H., Gupta, M., & Gupta, K. (2017) · Blood · doi:10.1182/blood-2017-05-782003 · Cited by 96
Neuronal and glial factors contributing to sex differences in opioid modulation of pain
Averitt, D. L., Eidson, L. N., Doyle, H. H., & Murphy, A. Z. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0127-4 · Cited by 95
Palmitoylethanolamide in the Treatment of Chronic Pain Caused by Different Etiopathogenesis
Gatti, A., Lazzari, M., Gianfelice, V., Paolo, A. D., Sabato, E., & Sabato, A. F. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01432.x · Cited by 101
Wang, X., Northcutt, A. L., Cochran, T. A., Zhang, X., Fabisiak, T., Haas, M. E., Amat, J., Li, H., Rice, K. C., Maier, S. F., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00225 · Cited by 94
Self-citationStructure–Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists
Selfridge, B. R., Wang, X., Zhang, Y., Yin, H. H., Grace, P. M., Watkins, L. R., Jacobson, A. E., & Rice, K. C. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00426 · Cited by 94
Self-citationEl‐Hage, N., Podhaizer, E. M., Sturgill, J., & Hauser, K. F. (2011) · Immunological Investigations · doi:10.3109/08820139.2011.561904 · Cited by 96
Codeine-induced hyperalgesia and allodynia: investigating the role of glial activation
Johnson, J. L., Rolan, P. E., Johnson, M., Bobrovskaya, L., Williams, D. B., Johnson, K., Tuke, J., & Hutchinson, M. R. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.121 · Cited by 92
Self-citationChiang, C., Sessle, B. J., & Dostrovsky, J. O. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0801-6 · Cited by 93
Mattioli, T.-A. M., Leduc‐Pessah, H., Skelhorne‐Gross, G., Nicol, C. J. B., Milne, B., Trang, T., & Cahill, C. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097361 · Cited by 89
Sterile Neuroinflammation and Strategies for Therapeutic Intervention
Banjara, M., & Ghosh, C. (2017) · International Journal of Inflammation · doi:10.1155/2017/8385961 · Cited by 92
Hutchinson, M. R., Ramos, K. M., Loram, L. C., Wieseler, J. L., Sholar, P. W., Kearney, J. J., Lewis, M. T., Crysdale, N. Y., Zhang, Y., Harrison, J. A., et al. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.09.046 · Cited by 87
Self-citationQiu, S., Feng, Y., LeSage, G., Zhang, Y., Stuart, C. A., He, L., Li, Y., Caudle, Y., Peng, Y., & Yin, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400106 · Cited by 82
Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice
Zhang, Y., Li, H., Li, Y., Sun, X., Zhu, M., Hanley, G., LeSage, G., & Yin, D. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.11.063 · Cited by 82
Gabapentin improves cold-pressor pain responses in methadone-maintained patients
Compton, P. A., Kehoe, P., Sinha, K., Torrington, M. A., & Ling, W. W. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.01.006 · Cited by 81
Zhang, X., Cui, Y., Cui, Y., Chen, Y., Na, X.-D., Chen, F., Wei, X., Li, Y.-Y., Liu, X., & Xin, W. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.09.017 · Cited by 80
Ahlbeck, K. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.545379 · Cited by 78
Wu, Y. H., Lousberg, E. L., Moldenhauer, L. M., Hayball, J. D., Robertson, S. A., Coller, J. K., Watkins, L. R., Somogyi, A. A., & Hutchinson, M. R. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.01.012 · Cited by 78
Self-citationIntrathecal Morphine Attenuates Recovery of Function after a Spinal Cord Injury
Hook, M. A., Moreno, G. L., Woller, S. A., Puga, D. A., Hoy, K. C., Balden, R., & Grau, J. W. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0710 · Cited by 77
Pioglitazone prevents morphine antinociception tolerance and withdrawal symptoms in rats
Ghavimi, H., Hassanzadeh, K., Maleki‐Dizaji, N., Azarfardian, A., Ghasami, S., Zolali, E., & Charkhpour, M. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-0996-y · Cited by 76
Potential of Glial Cell Modulators in the Management of Substance Use Disorders
Jones, J. D. (2020) · CNS Drugs · doi:10.1007/s40263-020-00721-9 · Cited by 79
The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats
Hao, S., Liu, S., Zheng, X., Zheng, W., Ouyang, H., Mata, M., & Fink, D. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.197 · Cited by 74
Jones, J. D., Bisaga, A. M., Metz, V. E., Manubay, J. M., Mogali, S., Ciccocioppo, R., Madera, G., Doernberg, M., & Comer, S. D. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1508789 · Cited by 74
Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations
Arout, C. A., Edens, E., Petrakis, I. L., & Sofuoglu, M. (2015) · CNS Drugs · doi:10.1007/s40263-015-0255-x · Cited by 80
Campillo, A., Cabañero, D., Romero, A., Garcı́a-Nogales, P., & Puig, M. M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.059 · Cited by 72
Jacobsen, J. H. W., Watkins, L. R., & Hutchinson, M. R. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00006-3 · Cited by 72
Self-citationRolan, P. E., Gibbons, J. A., He, L., Chang, E., Jones, D., Gross, M. I., Davidson, J. B., Sanftner, L. M., & Johnson, K. W. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03270.x · Cited by 70
Self-citationBai, L., Zhai, C.-H., Han, K. S., Li, Z., Qian, J., Jing, Y., Zhang, W., & Xu, J. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-014-1483-7 · Cited by 68
Ghazizadeh‐Hashemi, M., Ghajar, A., Shalbafan, M., Ghazizadeh‐Hashemi, F., Afarideh, M., Malekpour, F., Ghaleiha, A., Ardebili, M. E., & Akhondzadeh, S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.057 · Cited by 67
Liu, L., Coller, J. K., Watkins, L. R., Somogyi, A. A., & Hutchinson, M. R. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.016 · Cited by 66
Self-citationWhy mu‐opioid agonists have less analgesic efficacy in neuropathic pain?
Martínez‐Navarro, M., Maldonado, R. J., & Baños, J.-E. (2018) · European Journal of Pain · doi:10.1002/ejp.1328 · Cited by 65
Wang, Q., Zhou, H., Gao, H., Chen, S., Chu, C., Wilson, B. C., & Hong, J. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-32 · Cited by 65
Drossman, D. A., Morris, C. B., Edwards, H., Wrennall, C. E. D., Weinland, S. R., Aderoju, A. O., Kelapure, R., Hu, Y., Dalton, C. B., Bouma, M. H., et al. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.142 · Cited by 65
Therapeutic Developments Targeting Toll‐like Receptor‐4‐Mediated Neuroinflammation
Li, J., Csakai, A., Jin, J., Zhang, F., & Yin, H. H. (2015) · ChemMedChem · doi:10.1002/cmdc.201500188 · Cited by 65
Kwok, Y. H., Hutchinson, M. R., Gentgall, M., & Rolan, P. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044232 · Cited by 64
Self-citationJohnson, J. L., Hutchinson, M. R., Williams, D. B., & Rolan, P. E. (2012) · Cephalalgia · doi:10.1177/0333102412467512 · Cited by 63
Self-citationOpioid-induced microglia reactivity modulates opioid reward, analgesia, and behavior
Green, J. M., Sundman, M., & Chou, Y. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104544 · Cited by 63
Grau, J. W., Huie, J. R., Lee, K. H., Hoy, K. C., Huang, Y.-J., Turtle, J. D., Strain, M. M., Baumbauer, K. M., Miranda, R. M., Hook, M. A., et al. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00100 · Cited by 64
Smith, H. S. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/201 · Cited by 61
Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders
Simpson, S., Mclellan, R., Wellmeyer, E., Matalon, F., & George, O. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10022-7 · Cited by 63
Ultra-Low Dose Naltrexone Attenuates Chronic Morphine-Induced Gliosis in Rats
Mattioli, T.-A. M., Milne, B., & Cahill, C. M. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-22 · Cited by 56
Does Traumatic Brain Injury Cause Risky Substance Use or Substance Use Disorder?
Olsen, C. M., & Corrigan, J. D. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.07.013 · Cited by 66
Sex differences in innate immunity and its impact on opioid pharmacology
Doyle, H. H., & Murphy, A. Z. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23852 · Cited by 56
Impact of sex on pain and opioid analgesia: a review
Fullerton, E. F., Doyle, H. H., & Murphy, A. Z. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.08.001 · Cited by 55
Toll-Like Receptor 4 Is a Regulator of Monocyte and Electroencephalographic Responses to Sleep Loss
Wisor, J. P., Clegern, W. C., & Schmidt, M. A. (2011) · Sleep · doi:10.5665/sleep.1274 · Cited by 54
Low-dose naltrexone as a treatment for chronic fatigue syndrome
Bolton, M. J., Chapman, B. P., & van Marwijk, H. (2020) · BMJ Case Reports · doi:10.1136/bcr-2019-232502 · Cited by 53
Metadata
- Authors
- Hutchinson, M. R., Bland, S. T., Johnson, K. W., Rice, K. C., Maier, S. F., & Watkins, L. R.
- Affiliations
- University of Colorado Boulder (US)
- Avigen Inc., Alameda, CA, USA
- National Institute on Drug Abuse (US)
- Corresponding author
- Hutchinson, Mark R.
- ORCID
- Venue
- The Scientific World JOURNAL
- Publisher
- Wiley
- Published
- 2007
- Volume
- 7
- Pages
- 98-111
- ISSN
- 1537-744X (ISSN-L)
- PMC
- PMC5901235
- OpenAlex
- W2103801183
- Cited by
- 359
- References
- 61
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 14 · 2023: 11 · 2022: 14 · 2021: 12 · 2020: 18 · 2019: 19 · 2018: 26 · 2017: 21 · 2016: 24 · 2015: 20 · 2014: 25 · 2013: 19 · 2012: 24
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- The Scientific World JOURNAL (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health (DA015642, DA017670, DE017782)
- National Health and Medical Research Council (DA015642, DA017670, DE017782)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- glial activation, TLR4, neuropathic pain, opioid analgesia, opioid tolerance, opioid use disorder, opioid reward, conditioned place preference, dopamine, nucleus accumbens, morphine
- MeSH terms
- Analgesics, Opioid, Animals, Humans, Neuroglia, Pain, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
